These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3540497)

  • 21. The effect of antibacterial drugs on the ultrastructure of Mycobacterium leprae in human skin.
    Edwards RP; Draper GJ; Draper P
    Lepr Rev; 1972 Dec; 43(4):173-80. PubMed ID: 4579978
    [No Abstract]   [Full Text] [Related]  

  • 22. Uptake of purine and pyrimidine nucleosides by macrophage-resident Mycobacterium leprae: 3H-adenosine as an indicator of viability and antimicrobial activity.
    Harshan KV; Mittal A; Prasad HK; Misra RS; Chopra NK; Nath I
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):526-33. PubMed ID: 2205687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapsone, folate synthesis and M. leprae.
    Chatterjee BR
    Indian J Lepr; 1990; 62(4):459-66. PubMed ID: 2086681
    [No Abstract]   [Full Text] [Related]  

  • 24. Dapsone resistance in leprosy.
    Browne SG
    Trans St Johns Hosp Dermatol Soc; 1973; 59(2):225-9. PubMed ID: 4602407
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Sensitivity of Mycobacterium leprae to dapsone, studied in the rat.
    Pattyn SR; Verdoolaeghe-Van Loo G
    Int J Lepr Other Mycobact Dis; 1974; 42(1):72-3. PubMed ID: 4606751
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary dapsone resistance in leprosy.
    Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
    Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
    Pattyn SR
    Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide.
    Gelber RH
    Lepr Rev; 1987 Dec; 58(4):407-11. PubMed ID: 3323753
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae].
    Guelpa-Lauras CC; Grosset J; Truffot-Pernot C; Giroir AM
    Acta Leprol; 1982; (86-87):69-75. PubMed ID: 6815999
    [No Abstract]   [Full Text] [Related]  

  • 32. A rapid method for viability and drug sensitivity of Mycobacterium leprae cultured in macrophages and using fluorescein diacetate.
    Bhagria A; Mahadevan PR
    Indian J Lepr; 1987; 59(1):9-19. PubMed ID: 2440960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dapsone resistance in North India.
    Sreevatsa ; Girdhar BK; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(3):514-8. PubMed ID: 3913706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mouse footpad test--sensitive to small proportions of drug-resistant bacilli in a sample of M. leprae.
    Almeida JG; Joseph PS; Sarangapani G; Chacko CJ
    Indian J Lepr; 1984; 56(1):10-4. PubMed ID: 6384379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permeability of Mycobacterium leprae to dapsone: alteration by purification procedures.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Lepr India; 1981 Apr; 53(2):160-2. PubMed ID: 6789004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinations of drugs against Mycobacterium leprae studied in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of secondary dapsone resistance in Nepal.
    Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
    Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.